Press release
Global Hemoglobinopathy Market 2022- New Technological Development Projecting Massive Growth till 2032
In a new report titled "Hemoglobinopathy Market: Global Industry Analysis and Forecast, 2016-2024", Persistence Market Research analyzes the performance of the global hemoglobinopathy market over an eight-year period and provides insights on the key factors and trends likely to influence the market during the forecast period (2016 - 2024). In terms of revenue, the global hemoglobinopathy market is projected to register a healthy CAGR of 8.3% over the forecast period owing to various factors, on which Persistence Market Research offers detailed insights.Request For Free Sample Report of "Hemoglobinopathy Market"@ https://www.persistencemarketresearch.com/samples/10007
Market dynamics
Most health insurance companies, including government programs in the U.S. and Europe provide insurance coverage for hemoglobinopathy therapy under the CPT code. This creates a favorable environment for the growth of the global hemoglobinopathy market. Various government initiatives are being carried out for detection and management of hemoglobinopathy in high disease prevalence regions across the globe, giving a fillip to the global hemoglobinopathy market. Advancements in diagnosis techniques have led to the development of new tests that have enabled clinicians to provide effective diagnosis and therapeutic assistance to patients. Rising awareness about these disorders coupled with various public and private initiatives is also fueling the growth of the global hemoglobinopathy market in the regions with a high prevalence of sickle cell anemia and thalassemia.
Lack of awareness regarding hemoglobinopathy disorders among the populace especially in underdeveloped countries is a major factor hampering growth of the global hemoglobinopathy market. The lack of a permanent cure for hemoglobinopathy disorder is also one of the restraints affecting the global hemoglobinopathy market.
Companies
Abbott Diagnostics
Bio-Rad Laboratories, Inc.
Danaher Corp.
Mindray Medical International Ltd
Nexcelom Bioscience LLC.
Nihon Kohden Europe Ltd
PerkinElmer Inc.
Siemens Healthineers
Sysmex Europe GmbH
Others
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/10007
Market forecast
The global hemoglobinopathy market is segmented based on indication type, test type, end users, and region. Based on indication, the market is segmented into sickle cell disease, alpha thalassemia, and beta thalassemia. Beta thalassemia segment is expected to register a significant CAGR of 8.7% during the forecast period. Sickle cell disease segment is anticipated to grow with a CAGR of 8.3% over the forecast period.
The market has been segmented based on major types of diagnostic tests such as red blood cell (RBC) count test, genetic testing, hemoglobin by high performance liquid chromatography (HPLC) test, hemoglobin isoelectric (Hb IEF) focusing, hemoglobin electrophoresis (Hb ELP) test, and hemoglobin solubility test.
The genetic testing segment is expected to expand at the highest CAGR of 9.2% over the forecast period due to increasing adoption of preventive measures such as genetic counseling and testing. Increasing popularity of prenatal and premarital genetic screening make these tests an attractive opportunity for market players.
Based on end users, the market has been segmented into hospitals, diagnostic laboratories, and clinics. The diagnostic laboratories segment is anticipated to account for the highest market share over the forecast period, registering a CAGR of 8.9% due to availability of dedicated equipment, reagents, and trained technicians required to perform rather complex diagnostic procedures like genetic testing, Hb HPLC, and isoelectric focusing.
The global hemoglobinopathy market has been segmented into five major regions: North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). North America and Europe are expected to dominate the global hemoglobinopathy market with maximum market share in 2016. North America and Europe collectively have been expected to account for more than 50% of the total global hemoglobinopathy market share in terms of value in 2016. Among emerging markets, Asia Pacific is estimated to exhibit the highest CAGR of 9.3% over the forecast period, due to an increase in the diagnosis rate.
Competitive landscape
Some key players in the global hemoglobinopathy market identified in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc., Danaher Corporation, Mindray Medical International Ltd., Nexcelom Bioscience LLC., Nihon Kohden Corporation, PerkinElmer Inc., Siemens Healthineers, and Sysmex Corporation.
The individual strategies of these companies in terms of increasing focus on rare diseases, initiatives to increase disease awareness, and enhancing distribution base have been discussed. The report concludes with strategic recommendations for players already present in the market and new players planning to enter the global hemoglobinopathy market, which could help them in the long run.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/10007
Key Questions Answered in This Report.
What are the Roadblocks for Hemoglobinopathy Market Suppliers?
What are the Key Opportunities for Hemoglobinopathy Market Manufacturers?
How is Focus on Safety Influencing Hemoglobinopathy Market Demand?
What is the Regulatory Impact on Global Sales of Hemoglobinopathy Market?
Which Region Offers the Largest Opportunity for Sales of Hemoglobinopathy Market?
Where Does the U.S. Stand in the Market for Hemoglobinopathy Market?
What Is the Outlook for Hemoglobinopathy Market Manufacturers in China?
Why is Germany a Lucrative Market for Hemoglobinopathy Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Hemoglobinopathy Market?
Why is There High Demand for Tires in Hemoglobinopathy Market?
Why are Sales of Hemoglobinopathy Market Surging?
Related Market Research Reports:
Biosimilars Market: https://www.persistencemarketresearch.com/market-research/biosimilars-market.asp
Viral Vector Manufacturing Market: https://www.persistencemarketresearch.com/market-research/viral-vector-manufacturing-market.asp
Transcatheter Heart Valve Replacement Repair Market: https://www.persistencemarketresearch.com/market-research/transcatheter-heart-valve-replacement-repair-market.asp
Herpes Markers Testing Market: https://www.persistencemarketresearch.com/market-research/herpes-markers-testing-market.asp
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hemoglobinopathy Market 2022- New Technological Development Projecting Massive Growth till 2032 here
News-ID: 2835281 • Views: …
More Releases from Persistence Market Research
Medical Devices Packaging Market Projected at US$ 41.57 Billion by 2032
The global healthcare industry has been evolving at a rapid pace with technological advancements, increased healthcare spending, and the rising prevalence of chronic diseases. As medical devices become more sophisticated, the demand for secure, reliable, and innovative packaging solutions continues to grow. Medical device packaging plays a vital role not only in protecting sensitive equipment from physical and environmental damage but also in maintaining sterility, ensuring compliance with regulatory standards,…
Wind Power Converter Market Projected to Grow from US$25.8 Billion in 2025 to US …
The global energy landscape is undergoing a significant transformation, with renewable energy sources taking center stage. Among these, wind energy stands out as a pivotal contributor to sustainable power generation. Central to the efficient harnessing of wind energy are wind power converters, which play a crucial role in converting the variable output of wind turbines into stable, grid-compatible electricity. This article delves into the dynamics of the wind power converter…
Conformal Coating in Electronics Market to Grow from US$5.2 Billion in 2025 to U …
Conformal coating is a critical process in the electronics industry, providing essential protection to electronic components and printed circuit boards (PCBs). This protective layer ensures the longevity and reliability of electronic devices by shielding them from environmental factors such as moisture, dust, chemicals, and temperature fluctuations. As the demand for miniaturized and high-performance electronics continues to rise, the role of conformal coatings becomes increasingly significant Conformal coating refers to a…
Polyurethane Catalyst Market to Reach US$ 3.96 Billion by 2032 Driving Growth, S …
Polyurethane (PU) catalysts are specialized chemicals that play a critical role in the production of polyurethane materials. These catalysts accelerate and control the chemical reaction between polyols and isocyanates, which form polyurethane products. Polyurethanes are versatile materials used in flexible and rigid foams, coatings, adhesives, sealants, elastomers, textiles, and other applications. The performance of polyurethane products heavily depends on the type and efficiency of the catalyst used in their production.
According…
More Releases for Hemoglobinopathy
Hemoglobinopathy Treatment Market Future Prediction Report By 2032
The global Hemoglobinopathy Treatment market was valued at approximately USD 8.28 billion in 2022 and is projected to reach around USD 20.70 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.6% from 2023 to 2032.
The growth of the market is primarily attributed to a surge in the cases of hemoglobinopathies, as well as the public awareness of hemoglobin disorders. According to the World Health Organization, about 1.1%…
Hemoglobinopathy Treatment Advancements: Global Market Forecast 2024
"The Business Research Company recently released a comprehensive report on the Global Hemoglobinopathies Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The hemoglobinopathies treatment market size…
Empowering Lives: Exploring Breakthroughs in the Hemoglobinopathy Market
Hemoglobinopathy Market 2023
The health systems and data are moving to cloud. Healthcare vertical has several sprawling networks, inclusive of hospitals systems and universities, which could render an effective communication amongst doctor's offices, pharmacies, radiology labs, patients, health insurance companies, and likewise. Cloud-based platforms are actually making things like patient portals easily accessible along with interoperability. This would be the scene with XYZ market in the forecast period.
Get Free Sample Copy…
Hemoglobinopathy Market Industry Analysis - Hemoglobinopathy Market Size Driven …
The most recent study offered by Acumen Research and Consulting focuses Hemoglobinopathy Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Hemoglobinopathy Market trends in order to assess its current and future potential. Our Hemoglobinopathy Market analysis also provides market participants and new entrants with a comprehensive view of the…
The Hemoglobinopathy Market to grow through mobile apps
The Hemoglobinopathy Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent in…
Adult Hemoglobinopathy Testing Market See Incredible Growth During 2026
The worldwide market for adult hemoglobinopathy testing is anticipated to gradually gain momentum over the years to follow. In revenue terms, over the assessment time frame 2026, the worldwide market is estimated to account for a market evaluation of US$ XXX.X Million towards the end of 2026. The worldwide market is likely to expand at a X% CAGR all through the calculated period 2026.
Hemoglobinopathy is typically an inherited disease, incorporating…
